Anti-Tumor Therapy Mediated by 5-Fluorocytosine and a Recombinant Fusion Protein Containing human epidermal growth factor and Yeast Cytosine Deaminase
碩士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 101 === Currently, there are several antiangiogenetic drugs targeting VEGF/VEGF receptor that were approved by the Food and Drug Administration for many cancer types, which works affectively in breast, colon cancer patients, siginificant tumor regression is observed...
Main Authors: | Hao-Qun Lin, 林浩群 |
---|---|
Other Authors: | C. Allen Chang |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/28010962887003514779 |
Similar Items
-
Anti-tumor targeting therapy using recombinant fusion proteins (RGD4C-yeast cytosine deaminase series) with 5-fluorocytosine
by: Li-Chen Chen, et al.
Published: (2016) -
Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
by: Yuedi Ding, et al.
Published: (2020-06-01) -
Adenovirus-mediated interleukin-12 gene transfer combined with <it>cytosine deaminase </it>followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice
by: Kim Samyong, et al.
Published: (2005-05-01) -
Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo
by: Xiao-Ping Yang, et al.
Published: (2015-01-01) -
Characteristics and efficacy of cytosine and cytidine deaminase
by: Qusay Chalabi, et al.
Published: (2007-01-01)